Suchergebnisse - "Brand, Lucas"

PubPharm (8)

1

Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Dylgjeri, E. | McNair, C. | Goodwin, J. | +22

2

PARP-1 regulates DNA repair factor availability

enthalten in: EMBO molecular medicine | 2018

von Schiewer, M. | Mandigo, A. | Gordon, N. | +29

3

MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von de Leeuw, R. | McNair, C. | Schiewer, M. | +14

4

EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer

enthalten in: Oncotarget | 2015

von Brand, L. | Olson, M. | Ravindranathan, P. | +7

5

FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants

enthalten in: The Prostate | 2013

von Bohrer, L. | Liu, P. | Zhong, J. | +5

6

Androgen receptor gene rearrangements : new perspectives on prostate cancer progression

enthalten in: Current drug targets | 2013

von Brand, L. | Dehm, S.

7

Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines

enthalten in: Cancer research | 2013

von Li, Y. | Chan, S. | Brand, L. | +3

CommentIn: Eur Urol. 2013 Jul;64(1):169-70. - PMID 23746320

8

Genome-wide identification of KANADI1 target genes

enthalten in: PloS one | 2013

von Merelo, P. | Xie, Y. | Brand, L. | +5

1
[1]